Ohcanbohtosat - Sohn, Joohyuk

Aiddostahte ozu
  1. 1
    Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy

    Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy Dahkki Park, Hye Yoon, Lee, Hyeongrae, Sohn, Joohyuk, An, Suk Kyoon, Namkoong, Kee, Lee, Eun

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial

    Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of... Dahkki Lee, Kyung-Hun, Sohn, Joohyuk, Goodwin, Annabel, Usari, Tiziana, Lanzalone, Silvana, Im, Seock-Ah, Kim, Sung-Bae

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer

    Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer Dahkki Lee, Jeong Dong, Ryu, Won-Ji, Han, Hyun Ju, Kim, Tae Yeong, Kim, Min Hwan, Sohn, Joohyuk

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

    cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer Dahkki Sohn, Joohyuk, Liu, Shuying, Parinyanitikul, Napa, Lee, Jangsoon, Hortobagyi, Gabriel N., Mills, Gordon B., Ueno, Naoto T., Gonzalez-Angulo, Ana M.

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer

    Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer Dahkki Hyun, Kyung-A, Koo, Gi-Bang, Han, Hyunju, Sohn, Joohyuk, Choi, Wonshik, Kim, Seung-Il, Jung, Hyo-Il, Kim, You-Sun

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis

    Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis Dahkki Cha, Chihwan, Ahn, Sung Gwe, Yoo, Tae-Kyung, Kim, Kun Min, Bae, Soong June, Yoon, Changik, Park, Soeun, Sohn, Joohyuk, Jeong, Joon

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs

    Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs Dahkki Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Noguchi, Emi, Watanabe, Makiko, Sohn, Joohyuk, Lu, Yen‐Shen, Yap, Yoon‐Sim, Tamura, Kenji, Fujiwara, Yasuhiro

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

    Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review Dahkki Pandey, Kamal, An, Hee‐Jung, Kim, Seung Ki, Lee, Seung Ah, Kim, Sewha, Lim, Sun Min, Kim, Gun Min, Sohn, Joohyuk, Moon, Yong Wha

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide

    A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide Dahkki Kim, Gun Min, Kim, Joo Hoon, Kim, Ji Heung, Cho, Young Up, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Sohn, Joohyuk

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

    Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups Dahkki Johnston, Stephen, O’Shaughnessy, Joyce, Martin, Miguel, Huober, Jens, Toi, Masakazu, Sohn, Joohyuk, André, Valérie A. M., Martin, Holly R., Hardebeck, Molly C., Goetz, Matthew P.

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR

    Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR Dahkki Park, Hyung Seok, Han, Hyun Ju, Lee, Soohyeon, Kim, Gun Min, Park, Seho, Choi, Yeon A, Lee, Jeong Dong, Kim, Gi Moon, Sohn, Joohyuk, Kim, Seung Il

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy

    Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy Dahkki Kaufman, Peter A., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Grischke, Eva‐Maria, Andre, Valerie, Stoffregen, Clemens, Shekarriz, Sarah, Price, Gregory L., Carter, Gebra Cuyun, Sledge, George W.

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy

    Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy Dahkki Kim, Chang Gon, Sohn, Joohyuk, Chon, Hongjae, Kim, Joo Hoon, Heo, Su Jin, Cho, Hyunsoo, Kim, In Jung, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Gun Min

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results

    Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results Dahkki Park, Hyung Seok, Park, Seo-Jin, Kim, Jee Ye, Kim, Sanghwa, Ryu, Jaegyu, Sohn, Joohyuk, Park, Seho, Kim, Gun Min, Hwang, In Sik, Choi, Jong-Rak, Kim, Seung Il

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial

    S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial Dahkki Moon, Yong Wha, Lee, Soohyeon, Park, Byeong-Woo, Kim, Eun-Kyung, Kim, Seung Il, Koo, Ja Seung, Park, Seho, Kim, Min Jung, Chung, Hyun Cheol, Kim, Joo-Hang, Sohn, Joohyuk

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer

    Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer Dahkki Ahn, Sung Gwe, Lee, Jae-Hoon, Lee, Hak Woo, Jeon, Tae Joo, Ryu, Young Hoon, Kim, Kun Min, Sohn, Joohyuk, Yun, Mijin, Lee, Seung Ah, Jeong, Joon, Kim, Seung Il

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication

    Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication Dahkki Kim, Min Hwan, Lee, Soohyeon, Koo, Ja Seung, Jung, Kyung Hae, Park, In Hae, Jeong, Joon, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Park, Byeong-Woo, Kim, Joo-Hang, Sohn, Joohyuk

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy

    Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy Dahkki Jung, Minkyu, Koo, Ja Seung, Moon, Young Wha, Park, Byeong-Woo, Kim, Seung Il, Park, Seho, Lee, Soo Hyun, Hong, Soojung, Rha, Sun Young, Chung, Hyun Cheol, Kim, Joo Hang, Sohn, Joohyuk

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer

    Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer Dahkki Bae, Soong June, Kim, Jee Hung, Ahn, Sung Gwe, Jeung, Hei-Cheul, Sohn, Joohyuk, Kim, Gun Min, Kim, Min Hwan, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Jeong, Joon

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer

    The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer Dahkki Chae, Young Kwang, Gagliato, Debora de Melo, Pai, Sachin Gopalkrishna, Carneiro, Benedito, Mohindra, Nisha, Giles, Francis Joseph, Ramakrishnan-Geethakumari, Praveen, Sohn, Joohyuk, Liu, Shuying, Chen, Huiqin, Ueno, Naoto, Hortobagyi, Gabriel, Gonzalez-Angulo, Ana Maria

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: